Edwards Lifesciences (EW) Shares Outstanding (Weighted Average) (2009 - 2026)

Edwards Lifesciences' Shares Outstanding (Weighted Average) history runs 18 years deep, the most recent figure standing at $579.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 1.31% year-over-year to $579.2 million; the TTM figure through Mar 2026 stood at $579.2 million (down 1.31% YoY), while the FY2025 annual figure was $584.8 million, down 2.16% from the prior year.
• Shares Outstanding (Weighted Average) was $579.2 million for Q1 2026 at Edwards Lifesciences, down from $584.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $622.1 million in Q1 2022 to a low of $579.2 million in Q1 2026.
• Historically, Shares Outstanding (Weighted Average) has averaged $602.1 million across 5 years, with a median of $601.8 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) fell 0.18% in 2022, then slipped 2.6% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $619.0 million in 2022, then dropped by 1.99% to $606.7 million in 2023, then fell by 1.48% to $597.7 million in 2024, then slipped by 2.16% to $584.8 million in 2025, then slipped by 0.96% to $579.2 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $579.2 million (Q1 2026), $584.8 million (Q4 2025), and $584.7 million (Q3 2025), per Business Quant data.